NEW YORK, May 12 /PRNewswire-FirstCall/ -- InfuSystem Holdings, Inc. (OTC Bulletin Board: INHI; INHIW; INHIU), the leading provider of ambulatory infusion pumps and associated clinical services, today announced financial results and provided a business update for the first quarter of 2008.
Mr. Steve Watkins, chief executive officer, commented, "We are pleased with the results of our first full quarter of operations as a stand-alone public company, and have already begun to benefit from some of our early initiatives, as evidenced by an approximate 8 percent increase in revenues for the quarter, compared to results of InfuSystem, Inc. for the first quarter of last year, while under its prior ownership. Among of our first steps following the acquisition were adding key personnel; setting new quotas, incentive plans and training for the sales force; and beginning a rebranding and redesign of our marketing materials. We also continue to explore potential acquisition candidates that would complement our existing products and services, and benefit from our strong distribution across the U.S., which includes approximately 60% penetration of oncologist practices, and contracts with managed care organizations covering over 125 million managed care lives."
"With those first steps in place we look forward to the next phase of
our strategy which includes building the awareness of InfuSystem by
educating the payors, physicians, and patients, all of whom stand to
benefit from our ambulatory infusion pumps and associated clinical
services. Specifically, ambulatory infusion of chemotherapy is advantageous
to payors, including managed care organizations, because it is generally
less expensive than homecare or hospitalization and may help lower the
costs incurred to treat the side-effects that may accompany traditional
bolus treatment. Ambulatory infusion also benefits the patients through
improved efficacy of the drugs as well as greater patient comfort compared
'/>"/>
| SOURCE InfuSystem Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |